Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
| Autor: | María Soledad Castaño, Robin L. Bailey, Carolin Vegvari, Emanuele Giorgi, Claudio Fronterre, Anna Borlase, Aatreyee M. Das, Veronica Malizia, Matthew R. Graham, Tim C.D. Lucas, Jonathan I D Hamley, Peter J. Diggle, Jaspreet Toor, Panayiota Touloupou, Simon E. F. Spencer, Andreia Vasconcelos, Christopher N. Davis, Klodeta Kura, T. Déirdre Hollingsworth, Luc E. Coffeng, Epke A. Le Rutte, Kat S. Rock, Sake J. de Vlas, David J. Blok, Martin Walker, Edwin Michael, Joaquin M. Prada, Morgan E. Smith, Emma L Davis, Emily R. Adams, Benjamin Amoah, Nakul Chitnis, Ronald E. Crump, Seth Blumberg, Maryam Aliee, Travis C. Porco, Federica Giardina, Thomas M. Lietman, Michael S. Deiner, Graham F. Medley, Wilma A. Stolk, Diepreye Ayabina, Rocio Caja Rivera, Ching-I Huang, Roy M. Anderson, María-Gloria Basáñez, Aronrag Meeyai |
|---|---|
| Přispěvatelé: | Public Health, Health Economics (HE), Medical Research Council (MRC), The Task Force for Global Health |
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
wc_680 coronavirus Schistosomiasis wa_395 Medical and Health Sciences Microbiology Rare Diseases SDG 3 - Good Health and Well-being Environmental health Tropical Medicine Pandemic medicine wc_505 Humans neglected tropical diseases Pandemics Lymphatic filariasis 11 Medical and Health Sciences wa_105 business.industry SARS-CoV-2 Tropical disease Neglected Diseases COVID-19 modeling 06 Biological Sciences Biological Sciences medicine.disease Viewpoints Vector-Borne Diseases AcademicSubjects/MED00290 Visceral leishmaniasis Orphan Drug Infectious Diseases Good Health and Well Being Trachoma Neglected tropical diseases business Onchocerciasis Infection RA RC |
| Zdroj: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 8 Clinical Infectious Diseases, 72(8), 1463-1466. Oxford University Press Clinical Infectious Diseases Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America |
| ISSN: | 1058-4838 1537-6591 |
| Popis: | Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals. The COVID-19 pandemic has disrupted neglected tropical disease programs. Modelling shows the impact of this will vary across diseases. Once interventions are reintroduced, there are opportunities for mitigating the delay and accelerating progress towards the 2030 goals. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|